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Original Article

Quality of life of lung cancer patients
Prasobh UK, Soumya S*
Email: soumyasss1986@gmail.com

Abstract
Lung cancer is one of the commonest cancers where the individual’s quality of life is affected. Objectives: To assess
the Quality of Life of Lung Cancer patients using quality of life rating scale. Methods: The descriptive survey method
was used. The study was done among 30 patients of selected hospitals at Calicut, Kerala using EORTC QLQ C-30
quality of life questionnaire version 3 with lung cancer module EORTC- LC-13. Results: Findings show that the mean
QoL of patients with lung cancer was 52.27, the mean cognitive function 76.70, the mean emotional function 53.70,
the mean role functioning score was 40.0, the mean physical functioning was 38.60 and the mean social function score
was 36.00. Conclusions: The study concluded that there is a decrease in QoL among patients with lung cancer that
necessitates newer interventions in the treatment and management.
Keywords: Lung Cancer, Quality of Life, Oncology, Patients, Complications

Introduction
In India, in the last 20 years, behaviors related to lifestyle
have resulted in increased cancer burden (Tiwari et al.,
2015). The incidence of lung cancer among both genders
had increased in Delhi, Chennai, and Bengaluru. The
incidence and pattern of lung cancer vary depending
on geographic location, ethnicity, and prevalence of
smoking (Malik and Raina, 2015).
Quality of Life has been the endpoint for treatment
comparisons in advanced cancer and a primary indicator
of disease advancement. Quality of life depends on
factors like functional stress, impairment, perceptions,
and social opportunities (Heydarnejad, 2011). In a study
conducted in Boston among 151 patients with metastatic
nonsmall-cell lung cancer showed that prompt palliative
care leads to improved QoL and longer survival than
other patients who receive standard care (Temel et al.,
2010).
A descriptive study (Ma et al., 2014) was done in 376
patients with advanced lung cancer who has never
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received chemotherapy. The patients were from 43
centers. The tools used were the Functional Assessment
of Cancer Therapy-Lung (FACT-L) scale and Cloud
QOL System. The result of the study showed a
significant correlation between QoL and symptoms.
Symptoms like loss of appetite, difficulty in breathing,
and cough were identified. The study concluded that
these symptoms had a negative effect on QoL. A similar
descriptive study (Akin, 2010) was done in 154 patients
with lung cancer undergoing chemotherapy. The tools
used were the Memorial Symptom Assessment Scale and
the Quality of Life Index-Cancer Version. The physical
symptoms identified in this study were lack of energy,
loss of appetite, pain, and nausea. Emotional symptoms
like nervousness, insomnia, sadness, and worrying were
identified. It is shown that as the symptom distress
increases and quality of life score decreases. Females
and those belonging to low-income groups experienced
more symptom distress. The patients need frequent
evaluation and rendering constant support.
Stigma, depression, and QoL were studied in 192
patients with lung cancer using online questionnaires.
There is a negative impact on QoL due to stigma. There
was no significant difference between smokers and no
smokers. The study concluded that depression and lung
cancer stigma have a role in making variations in the
quality of life (Cataldo et al., 2012).
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Staff nurses are important in an oncology care unit as
they try to create a therapeutic setting by environmental
manipulations. Environmental manipulation may be
curative, reduction of factors contributing to patient’s
problems, and even counseling. As a nurse, they
should understand QoL from the patients’ perspective.
European Organization for Research and Treatment of
Cancer (EORTC) scale enables us to get a perspective
of QoL of patients and their needs. This study aims
to create awareness on QoL and provide insight into
measures that help increase patients’ well-being and
help nurses to deliver quality nursing care.

Objective
The objective of the study was to assess the Quality of
Life of Lung Cancer patients using QoL rating scale.

Materials and Methods
Permission was obtained from the Quality of Life Unit,
European Organization for Research and Treatment
of Cancer (EORTC) Data Center, Brussels, Belgium.
EORTC-QLQ C30 quality of life questionnaire version
3 with lung cancer module EORTC- LC 13 was used
for this descriptive survey (Bergman et al., 1994). The
study was undertaken in selected hospitals of Calicut
among 30 Lung Cancer patients. The patients were
admitted to the hospital with the disease or associated
discomfort, were taking chemotherapy from daycare
units or attending the outpatient department. Patients
who were disoriented or unconscious, not aware of
their illness, unable to communicate to the researcher
due to physical constraints (lack of time, anxiety,
critically ill, pain, and discomfort of the patient) were
excluded.
The EORTC QLQ-C30 is aimed at cancer patients
and is supplemented by tumor-specific questionnaire
modules for Lung Cancer (QLQ-LC13). Questions
from those questionnaires relate to the functioning
of subjects, the severity of symptoms, economic
difficulties associated with disease and treatment, and
overall QoL. The QLQ-C30 is composed of both
multi-item scales and single-item measures (Aaronson
et al., 1993). These include five functional scales, three
symptom scales, a global health status / QoL scale,
and six single items. The functioning of subjects is
assessed in physical functioning, role functioning,
emotional functioning, cognitive functioning, and
32

social functioning areas. The symptoms specific for
lung cancer questionnaire asks about the symptoms
such as dyspnea, cough, hemoptysis, loss of appetite,
fatigue, diarrhea, constipation, sleep disturbance,
pain, difficulty with swallowing, nausea and vomiting
and hair loss. The score ranged from 0 to 100. A high
score for a functional scale represents a high level of
functioning, a high score for the global health status /
QoL represents a high QoL. A high score for a symptom
scale represents a high level of symptomatology/
problems (Fayers et al., 2001).
Lung cancer patients admitted to these hospitals
with the disease or associated discomfort or taking
chemotherapy from Daycare units, or attending the
outpatient department was taken for study. Ethical
clearance was obtained from the selected hospital’s
institutional review board (Institutional Ethics
Committee, Malabar institute of medical Sciences Ltd,
Reg. No. ECR/301/inst/KL/2013). Patients with lung
cancer who were disoriented or unconscious, not aware
of their illness, and unable to communicate to the
researcher due to physical constraints were excluded.
To preclude issues of confidentiality, a pseudonym
was chosen for each participant by the researcher. The
self-reporting technique was used with a structured
interview schedule. After a brief self-introduction
about the study, the investigator established rapport
with the subjects and assured the confidentiality of
the responses. Written informed consent was collected
from all patients. The investigator recorded the
responses of the subjects. The analysis was done using
SPSS 16 version.

Results
Out of 30 samples, most, 13 (43.3 %) of the patients
were of 56-65 years, 25 (83.3%) were males. Most
15 (50%) of them were diagnosed between the last
6 months to one year, and 7 (23.3%) were diagnosed
within the last 6 months. There were 8 (26.7%) with the
disease duration of 1-3 years. Out of the 30 samples
selected, 21 (70%) had a history of smoking. Among
them, 16 (76.2%) were ex-smokers, and 1 (4.8) % was an
occasional smoker, and 4 (19%) were frequent smokers.
About 3(14.3 %) smoked cigarettes for <30years,
a majority 13 (61.9%) smoked for 30-50 years, and
5(23.8%) smoked for >50 years. Most 7(33.3%) of the
patients had started smoking at the age of 18-20 years,
and 6 (28.6%) had started at 15-17 years, and about 2
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(9.5%) had started smoking at an age less than 15 years
old. About 6 (28.6%) had smoked equal to or above
20 years. Among the smokers, 9 (42.9%) used to smoke
</= 10 cigarettes per day,9 (42.9%) used to smoke 11
to 20 cigarettes per day, and 3 (14.2%) of them used
to smoke > 20 cigarettes per day. Most- 9 (42.9%) of
them had quit smoking within 1 year. About 6 (28.5%)
of them quit about 1-3 years back.
Among the 30 samples, about 5 (16.7%) had passive
smoking, and 25 (83.3%) did not have any history of
passive smoking. About 20 (66.7%) had occupational
exposure, and 10 (33.3%) had no history of
occupational exposure to gas, fumes, and dust. Only 1
(3.3%) patient was an industrial worker, and 29 (97%)
had other types of occupation. About 15 (50%) had a
family history of cancer.
About 15 (50%) patients with lung cancer had reported
pain in the chest, 20 (66.7%) had cough and dyspnea.
Only 8 (26.7 %) patients had hemoptysis. Most 17
(56.7%) of the patients had no voice problems. Among
the patients, only 12 (40%) and 36.7% had stomatitis,
and dysphagia respectively. Majority 28 (93.3%) had
fatigue, 12 (40%) had recurrent chest infections.
Majority 23 (76.7%) had peripheral neuropathy. Among
the samples, 15 (50%) of them had alopecia, most 20
(66.7%) had pain in the arm or shoulder. Majority 24
(80%) had pain in other parts (throat and back).
About 19 (63.3%) received only chemotherapy, and 8
(26.7%) received had mixed therapies. Only 1 (3.3%)
had undergone surgery for lung cancer, and 2 (6.7%)
currently had only symptomatic treatment. Majority 28
(93.3%) were satisfied with the treatment they receive,
and 2 (6.7%) were not satisfied with the treatment they
received.
Table 1:
Quality of life of patients with Lung Cancer

Table 1 shows that the mean quality of life of patients
with Lung Cancer was 52.2. A marked decrease in
quality of life in all functional areas except in cognitive
function is noted.
Table 2:
Symptom scores of patients with Lung Cancer
Symptoms (N=30)

Mean

SD

Dyspnea

46.3

25.7

Cough

38.8

31.7

Hemoptysis

6.6

13.4

Sore mouth

16.6

25.8

Dysphagia

22.2

29.5

Peripheral neuropathy

41.1

30.0

Alopecia

38.8

41.1

Chest pain

33.3

34.0

Pain in arm or shoulder

41.1

34.7

Pain in other parts

41.2

37.9

Table 2 shows that the mean symptom scores of patients
with Lung Cancer using QLQ LC -13. The mean score
of scale dimensions ranged from 6.6 for hemoptysis
to 46.3 for dyspnea. The more pronounced symptoms
have a high mean score. Dyspnoea, pain on parts of the
body other than arm and shoulder, followed by pain in
arm or shoulder, were the most significant symptoms
with mean scores of 46.3, 41.2, and 41.1, respectively.
The QLQ-LC 13 scores of hemoptysis, sore mouth,
and dysphagia were lower and less common.
The item 13 of the QLQ LC 13 scale is used if
answered as yes’ to medication intake. About 22
(73.3%) of the selected patients used pain medications,
and 8 (26.7%) had not used any pain medications. Of
the 22 samples which used pain medications, it was
found to be helpful by many. The mean score for how
far the pain medication was helpful was 65.45, with a
standard deviation of 33.05. A score of 100 denotes
100% helpful.

Discussion

Areas (N=30)

Mean

SD

Global health status/QoL

52.2

16.7

Cognitive functioning

76.7

22.5

Emotional functioning

53.7

23.4

Role functioning

40.0

28.5

Social functioning

36.0

22.3

Functions

In this study, physical, social, and role functioning was
not satisfactory compared to emotional function. The
mean scores of physical, cognitive, and social functions
and role performance in this study ranged from 36
to 76.7. The mean score of emotional function was
53.7. Cognitive function has a high mean of 76.7. The
present study shows a marked decrease in quality of
life in all functional areas except in cognitive function.
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A study conducted by (Sawada et al., 2009) in
Brazil to assess the QoL of 30 patients with cancer
receiving chemotherapy using the EORTC QLQ-C30
questionnaire showed that mean scores of physical,
cognitive and social functions and role performance
ranged from 71.26 to 75.12. The mean score of
emotional function was 55.46. On the symptoms
scales, the mean score of 34.44, with the score for
pain 23.33 and fatigue, was 22.31. The study concluded
that the QoL was satisfactory except for the emotional
function.
Another study was done (Benbrahim et al., 2016) in
Morocco among 497 lung cancer patients. 91.8% of
patients were males, and 76.9% were in stages III and
IV cancers. The mean score of social functioning was
77.7, which was significantly higher. For the QLQLC13, Moroccan patients showed severe symptoms,
especially for dyspnea, cough, and chest pain.
In this study, on the symptom scales of QLQ-LC 13
the mean hemoptysis score was 6.6 to mean dyspnea
score 46.6. The patients showed severe symptoms for
dyspnea, pain on parts of the body other than arm and
shoulder, followed by pain in arm or shoulder were the
most significant symptoms.
In another study (Hechtner et al., 2019) done in 657
non-small cell lung cancer patients using the EORTC
tool shows poor global QOL. The main factor of poor
QoL is mental distress, ongoing treatment, respiratory
comorbidity, living on a disability pension. Better QoL
is seen among people belonging to high-income groups
and who are physically active.
In this study, the QoL in lung cancer patients is found
to be low except in the cognitive domain, and this
result show that supportive care is required for these
populations. Furthermore, a prior assessment of QoL
at the starting of their treatment provides baseline data
for health professionals and can be used to see the
variation in perceived QoL in later years.

Conclusions
The assessment of the quality of life in any cancer
patients can serve as a baseline to assess the prognosis
and survival. These assessments will help to develop
new interventional research to prevent the illness, to
promote health, and to alleviate the suffering. Many
34

areas in the promotive, as well as restorative healthcare
practices for patients with different stages of cancers
undergoing different treatments in lung cancer, must
be explored. Advanced studies will empower nurses to
produce a therapeutic environment to overcome the
disease.
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